Anatomic Pathology Services - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB510242881

Publication Date:

October 1, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Anatomic (or anatomical) pathology is the branch of medicine that studies the effect of disease on the structure of body organs, both as a whole (grossly) and microscopically. The primary role of anatomic pathology is to identify abnormalities that can help to diagnose disease and manage treatment.
The global market for Anatomic Pathology Services was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Anatomic Pathology Services was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Anatomic Pathology Services was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Anatomic Pathology Services was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Anatomic Pathology Services include Bio SB, BioGenex, Merck KGaA, Sakura Finetek and Thermo Fisher Scientific, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Anatomic Pathology Services, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Anatomic Pathology Services by region & country, by Type, and by Application.
The Anatomic Pathology Services market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anatomic Pathology Services.
麻豆原创 Segmentation
By Company
Bio SB
BioGenex
Merck KGaA
Sakura Finetek
Thermo Fisher Scientific
Segment by Type:
Histopathology
Cytopathology
Segment by Application
Hospital Laboratories
Clinical Laboratories
Other End Users
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Anatomic Pathology Services manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Anatomic Pathology Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Anatomic Pathology Services in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Anatomic Pathology Services Product Introduction
1.2 Global Anatomic Pathology Services 麻豆原创 Size Forecast
1.3 Anatomic Pathology Services 麻豆原创 Trends & Drivers
1.3.1 Anatomic Pathology Services Industry Trends
1.3.2 Anatomic Pathology Services 麻豆原创 Drivers & Opportunity
1.3.3 Anatomic Pathology Services 麻豆原创 Challenges
1.3.4 Anatomic Pathology Services 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Anatomic Pathology Services Players Revenue Ranking (2023)
2.2 Global Anatomic Pathology Services Revenue by Company (2019-2024)
2.3 Key Companies Anatomic Pathology Services Manufacturing Base Distribution and Headquarters
2.4 Key Companies Anatomic Pathology Services Product Offered
2.5 Key Companies Time to Begin Mass Production of Anatomic Pathology Services
2.6 Anatomic Pathology Services 麻豆原创 Competitive Analysis
2.6.1 Anatomic Pathology Services 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Anatomic Pathology Services Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anatomic Pathology Services as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Histopathology
3.1.2 Cytopathology
3.2 Global Anatomic Pathology Services Sales Value by Type
3.2.1 Global Anatomic Pathology Services Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Anatomic Pathology Services Sales Value, by Type (2019-2030)
3.2.3 Global Anatomic Pathology Services Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital Laboratories
4.1.2 Clinical Laboratories
4.1.3 Other End Users
4.2 Global Anatomic Pathology Services Sales Value by Application
4.2.1 Global Anatomic Pathology Services Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Anatomic Pathology Services Sales Value, by Application (2019-2030)
4.2.3 Global Anatomic Pathology Services Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Anatomic Pathology Services Sales Value by Region
5.1.1 Global Anatomic Pathology Services Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Anatomic Pathology Services Sales Value by Region (2019-2024)
5.1.3 Global Anatomic Pathology Services Sales Value by Region (2025-2030)
5.1.4 Global Anatomic Pathology Services Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Anatomic Pathology Services Sales Value, 2019-2030
5.2.2 North America Anatomic Pathology Services Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Anatomic Pathology Services Sales Value, 2019-2030
5.3.2 Europe Anatomic Pathology Services Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Anatomic Pathology Services Sales Value, 2019-2030
5.4.2 Asia Pacific Anatomic Pathology Services Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Anatomic Pathology Services Sales Value, 2019-2030
5.5.2 South America Anatomic Pathology Services Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Anatomic Pathology Services Sales Value, 2019-2030
5.6.2 Middle East & Africa Anatomic Pathology Services Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Anatomic Pathology Services Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Anatomic Pathology Services Sales Value
6.3 United States
6.3.1 United States Anatomic Pathology Services Sales Value, 2019-2030
6.3.2 United States Anatomic Pathology Services Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Anatomic Pathology Services Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Anatomic Pathology Services Sales Value, 2019-2030
6.4.2 Europe Anatomic Pathology Services Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Anatomic Pathology Services Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Anatomic Pathology Services Sales Value, 2019-2030
6.5.2 China Anatomic Pathology Services Sales Value by Type (%), 2023 VS 2030
6.5.3 China Anatomic Pathology Services Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Anatomic Pathology Services Sales Value, 2019-2030
6.6.2 Japan Anatomic Pathology Services Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Anatomic Pathology Services Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Anatomic Pathology Services Sales Value, 2019-2030
6.7.2 South Korea Anatomic Pathology Services Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Anatomic Pathology Services Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Anatomic Pathology Services Sales Value, 2019-2030
6.8.2 Southeast Asia Anatomic Pathology Services Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Anatomic Pathology Services Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Anatomic Pathology Services Sales Value, 2019-2030
6.9.2 India Anatomic Pathology Services Sales Value by Type (%), 2023 VS 2030
6.9.3 India Anatomic Pathology Services Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Bio SB
7.1.1 Bio SB Profile
7.1.2 Bio SB Main Business
7.1.3 Bio SB Anatomic Pathology Services Products, Services and Solutions
7.1.4 Bio SB Anatomic Pathology Services Revenue (US$ Million) & (2019-2024)
7.1.5 Bio SB Recent Developments
7.2 BioGenex
7.2.1 BioGenex Profile
7.2.2 BioGenex Main Business
7.2.3 BioGenex Anatomic Pathology Services Products, Services and Solutions
7.2.4 BioGenex Anatomic Pathology Services Revenue (US$ Million) & (2019-2024)
7.2.5 BioGenex Recent Developments
7.3 Merck KGaA
7.3.1 Merck KGaA Profile
7.3.2 Merck KGaA Main Business
7.3.3 Merck KGaA Anatomic Pathology Services Products, Services and Solutions
7.3.4 Merck KGaA Anatomic Pathology Services Revenue (US$ Million) & (2019-2024)
7.3.5 Sakura Finetek Recent Developments
7.4 Sakura Finetek
7.4.1 Sakura Finetek Profile
7.4.2 Sakura Finetek Main Business
7.4.3 Sakura Finetek Anatomic Pathology Services Products, Services and Solutions
7.4.4 Sakura Finetek Anatomic Pathology Services Revenue (US$ Million) & (2019-2024)
7.4.5 Sakura Finetek Recent Developments
7.5 Thermo Fisher Scientific
7.5.1 Thermo Fisher Scientific Profile
7.5.2 Thermo Fisher Scientific Main Business
7.5.3 Thermo Fisher Scientific Anatomic Pathology Services Products, Services and Solutions
7.5.4 Thermo Fisher Scientific Anatomic Pathology Services Revenue (US$ Million) & (2019-2024)
7.5.5 Thermo Fisher Scientific Recent Developments
8 Industry Chain Analysis
8.1 Anatomic Pathology Services Industrial Chain
8.2 Anatomic Pathology Services Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Anatomic Pathology Services Sales Model
8.5.2 Sales Channel
8.5.3 Anatomic Pathology Services Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Bio SB
BioGenex
Merck KGaA
Sakura Finetek
Thermo Fisher Scientific

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.